UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010928
Receipt number R000012056
Scientific Title Adipocytokine regulation by antihypertensive drugs in patients with essential hypertension
Date of disclosure of the study information 2013/07/01
Last modified on 2019/12/16 15:08:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Adipocytokine regulation by antihypertensive drugs in patients with essential hypertension

Acronym

Adipocytokine regulation by antihypertensive drugs in patients with essential hypertension

Scientific Title

Adipocytokine regulation by antihypertensive drugs in patients with essential hypertension

Scientific Title:Acronym

Adipocytokine regulation by antihypertensive drugs in patients with essential hypertension

Region

Japan


Condition

Condition

Hypertension

Classification by specialty

Cardiology Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the regulation of adipocytokines's expression by angiotensin 2 type 1 receptor antagonists and calcium blocker.

Basic objectives2

Others

Basic objectives -Others

To investigate the functional role of angiotensin 2 type 1 receptor blockers (ARBs) in cardiovascular diseases including hypertension via the regulation of adipocytokines.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The plasma levels of adipocytokines (Adiponectin, Omentin, Aedipolin, C1q/TNF-related protein (CTRP)-1,6,9, FAM132B, FSTL-1, C1ORF54, Neuron-derived neurotrophic factor (NDNF)) after 4 months.

Key secondary outcomes

Blood pressure
Clinical data


Base

Study type


Study design

Basic design

Factorial

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

The hypertensive patients under amlodipine administration are intended for enrolement of this study. The patients are assigned to Group A (amlodipine).

Interventions/Control_2

The hypertensive patients under amlodipine administration are intended for enrolement of this study. The patients are assigned to Group B (Olmesartan or Telmisartan). As to Group B, the patiens are assigned to Olmesartan or Telmisartan at random.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The hypertensive patients under amlodipine administration for more than 3 months are intended for enrolement of this study.
1. Age; over 20 years old
2. Clinical data
AST<100IU/L
ALT<100IU/L
Cre<1.5mg/dl
3. Informed consent is needed.

Key exclusion criteria

1. The patients under calcium blocker other than amlodipine.
2. Uncontroled hypertensive patients with over 140mmHg (systolic) or 90mmHg (diastolic).
3. The patients with bilateral renal artery stenosis or the patients of 1 kidney with renal artery stenosis.
4. The patients with malignancy needed chemotherapy.
5. The patients who has experienced serious side effects for angiotensin receptor type 1 blocker or calcium blocker.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Noriyuki Ouchi

Organization

Nagoya Universtiy School of Medicine

Division name

Molecular Cardiovascular Medicine

Zip code


Address

65 Tsurumaicho, Showa-ku, Nagoya, Aichi, Japan

TEL

+81-52-744-2147

Email

nouchi@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Koji Ohashi

Organization

Nagoya University School of Medicine

Division name

Molecular Cardiovascular Medicine

Zip code


Address

65 Tsurumaicho, Showa-ku, Nagoya, Aichi, Japan

TEL

+81-52-744-2147

Homepage URL


Email

ohashik@med.nagoya-u.ac.jp


Sponsor or person

Institute

Molecular Cardiovascular Medicine, Nagoya University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Molecular Cardiovascular Medicine, Nagoya University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

None

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋大学附属病院(愛知県)


Other administrative information

Date of disclosure of the study information

2013 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 06 Month 11 Day

Date of IRB

2013 Year 06 Month 11 Day

Anticipated trial start date

2013 Year 07 Month 01 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry

2016 Year 12 Month 15 Day

Date trial data considered complete

2016 Year 12 Month 15 Day

Date analysis concluded

2016 Year 12 Month 15 Day


Other

Other related information



Management information

Registered date

2013 Year 06 Month 11 Day

Last modified on

2019 Year 12 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012056


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name